Does radiographic emphysema correlate with low bone mineral density?

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 2, 2012, Pages 125-130

  Bon, Jessica ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

emphysema; osteoporosis; systemic inflammation

Indexed keywords

BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INFLAMMATION; LUNG EMPHYSEMA; OSTEOLYSIS; OSTEOPOROSIS; REVIEW; SYSTEMIC DISEASE; THORAX RADIOGRAPHY;

AGED; BONE DENSITY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PULMONARY EMPHYSEMA; RISK FACTORS; UNITED STATES;

EID: 84856674645     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834f8194     Document Type: Review

References (68)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555. (Pubitemid 47403272)
2. Agusti AGN. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:367-370. (Pubitemid 41699698)
3. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 2003; 114:10-14. (Pubitemid 36126509)
4. de Vries F, van Staa TP, Bracke MSGM, et al. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005; 25:879-884. (Pubitemid 40667687)
5. Graat-Verboom L, Spruit MA, van den Borne BE, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med 2009; 103:1143-1151.
6. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD. Results from TORCH. Chest 2009; 136:1456-1465.
7. Ohara T, Hirai T, Muro S, et al. Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest 2008; 134:1244-1249.
8. Bon J, Fuhrman CR, Weissfeld JL, et al. Radiographic emphysema predicts & low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med 2011; 183:885-890.
9. U.S. Department of Health and Human Services. Bone Health and Osteo porosis: A report of the surgeon general. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General, 2004.
10. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178:738-744.
11. McAllister DA, Maclay JD, Mills NL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176:1208-1214. (Pubitemid 350256474)
12. Goldstein MF, Fallon JJ Jr, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116:1733-1749. (Pubitemid 30012719)
13. Dubois EF, Roder E, Dekhuijzen PN, et al. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest 2002; 121:1456-1463. (Pubitemid 34499655)
14. Gluck O, Colice G. Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest 2004; 125:1859-1876. (Pubitemid 38648422)
15. Franco C, Paz-Filho G, Gomes P, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteo-poros Int 2009; 20:1881-1887.
16. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65:215-220.
17. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 2005; 128:3792-3798. (Pubitemid 43062638)
18. Ensrud KE, Taylor BC, Paudel ML,et al. Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab 2009; 94:2773-2780.
19. Van Vliet M, Spruit MA, Verleden G, et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:1105-1111. (Pubitemid 43066645)
20. Svartberg J. Androgens and chronic obstructive pulmonary disease. Curr Opin Endocrinol Diabetes Obes 2010; 17:257-261.
21. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:1286-1293. (Pubitemid 39657192)
22. Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 2007; 18:1197-1202. (Pubitemid 47300271)
23. Cousins JM, Petit MA, Paudel ML, et al. Muscle power and physical activity are associated with bone strength in older men: the osteoporotic fractures in men study. Bone 2010; 47:205-211.
24. Englund U, Nordstrom P, Nilsson J, et al. Physical activity in middle-aged women and hip fracture risk: the UFO study. Osteoporos Int 2011; 22:499-505.
25. Cenci S, Weitzmann MN, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000; 106:1229-1237.
26. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332:305-311.
27. Zhu X, Gadgil AS, Givelber R, et al. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol 2009; 182:3270-3277.
28. Hurst JR, Perera WR, Wilkinson TMA, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:71-78. (Pubitemid 43069790)
29. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574-580. (Pubitemid 38901515)
30. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114:758-762. (Pubitemid 36776358)
31. TakayanagiH. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007; 7:292-304. (Pubitemid 46480961)
32. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378:1015-1026.
33. Bon JM, Leader JK, Weissfeld JL, et al. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One 2009; 4:e6865.
34. Yende S, Waterer GW, Tolley EA, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006; 61:10-16. (Pubitemid 43106971)
35. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164 (8 Pt 1):1414-1418. (Pubitemid 33124019)
36. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51:819-824. (Pubitemid 26274084)
37. Sambrook P, Cooper C. Osteoporosis. Lancet 2006; 367:2010-2018. (Pubitemid 43867702)
38. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005; 115:3318-3325. (Pubitemid 43121814)
39. Couillin I, Vasseur V, Charron S, et al. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol 2009; 183:8195-8202.
40. Churg A, Zhou S, Wang X, et al. The role of interleukin-1{beta} in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 2009; 40:482-490.
41. Churg A, Wang RD, Tai H, et al. Tumor necrosis factor-{alpha} drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004; 170:492-498. (Pubitemid 39209129)
42. Xiong Z, Leme AS, Ray P, et al. CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-a and IL-6 and promote cigarette smoke-induced emphysema. J Immunol 2011; 186:3206-3214.
43. Churg A, Dai J, Tai H, et al. Tumor necrosis factor-{alpha} is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002; 166:849-854.
44. Ruwanpura SM, McLeod L, Miller A, et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol 2011; 45:720-730.
45. Chen K, Pociask DA, McAleer JP, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 2011; 6:e20333.
46. Shead EF, Haworth CS, Barker H, et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010; 9:93-98.
47. Shead EF, Haworth CS, Gunn E, et al. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 2006; 174:306-311. (Pubitemid 44156609)
48. Ionescu AA, Nixon LS, Evans WD, et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000; 162 (3 Pt 1):789-794.
49. Bon JM, Zhang Y, Duncan SR, et al. Plasma inflammatory mediators asso-& ciated with bone metabolism in COPD. COPD 2010; 7:186-191.
50. Bolton CE, Stone MD, Edwards PH, et al. Circulating matrix metalloprotein-ase-9 and osteoporosis in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2009; 6:81-87.
51. Engsig MT, Chen QJ, Vu TH, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000; 151:879-889.
52. Ito I, Nagai S, Handa T, et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005; 172:1378-1382. (Pubitemid 43069810)
53. Horton JE, Raisz LG, Simmons HA, et al. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 1972; 177:793-795.
54. Mundy GR. Osteoporosis and inflammation. Nutr Rev 2007; 65 (12 Pt 2): S147-S151.
55. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-309.
56. Eghbali-Fatourechi G, Khosla S, Sanyal A, et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003; 111:1221-1230. (Pubitemid 36519939)
57. Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol 2009; 29:555-567.
58. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203:2673-2682. (Pubitemid 44833343)
59. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011; 105:1648-1654.
60. Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345:442-444. (Pubitemid 120014957)
61. Kirkham PA, Caramori G, Casolari P, et al. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184:796-802.
62. Nunez B, Sauleda J, Anto JM, et al. Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183:1025-1031.
63. Karayama M, Inui N, Suda T, et al. Antiendothelial cell antibodies in patients with COPD. Chest 2010; 138:1303-1308.
64. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:156-163.
65. Lee S-H, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13:567-569. (Pubitemid 46828488)
66. Kamen DL, Alele JD. Skeletal manifestations of systemic autoimmune diseases. Curr Opin Endocrinol Diabetes Obes 2010; 17:540-545.
67. Riches PL, McRorie E, Fraser WD, et al. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med 2009; 361:1459-1465.
68. Sugai E, Chernavsky A, Pedreira S, et al. Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis. J Clin Immunol 2002; 22:353-362. (Pubitemid 35305885)